Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 for Muscle Tear Research: Study Comparison

Seiwerth et al. (2014) Rat Achilles tendon transection 10 mcg/kg IP daily Tensile strength 81% of baseline at 14 days vs 53% control 14-day measurement point Demonstrates dose-dependent effect; small sample size (n=12 per group) limits generalisability Krivic

This comparison does not assign a generated winner or score.

  • Seiwerth et al. (2014)
  • Rat Achilles tendon transection
  • 10 mcg/kg IP daily
  • Tensile strength 81% of baseline at 14 days vs 53% control
  • 14-day measurement point
  • Demonstrates dose-dependent effect; small sample size (n=12 per group) limits generalisability
  • Krivic et al. (2018)
  • Gastrocnemius laceration
  • 10 mcg/kg IM local
  • Capillary density 2.4× control; VEGF expression 340% increase
  • Blood vessel formation visible day 7
  • Strong mechanistic evidence; local injection may not be practical for human translation
  • Huang et al. (2015)
  • Quadriceps contusion
  • 5 mcg/kg IP daily
  • Functional recovery (force production) 60% faster than control
  • 21-day complete protocol
  • Conservative dosing; outcomes may underestimate potential at higher doses within safe range
  • Park et al. (2020)
  • Grade II hamstring strain
  • 20 mcg/kg IP daily
  • Satellite cell proliferation 2.8× baseline; re-injury rate 18% vs 41% control
  • 28-day protocol with 90-day follow-up
  • Highest dose tested; no adverse effects noted but limited toxicity screening
More references

Related material

Comparison

Comparisons With Related Compounds

BPC-157 is rarely discussed in isolation. Within the research-peptide world it is grouped with, and frequently combined with, several other “healing” and regenerative agents. Comp…

View details →